OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CXCL8 Facilitates the Survival and Paclitaxel-Resistance of Triple-Negative Breast Cancers
Maolin Yi, Chengcheng Peng, Bingxiang Xia, et al.
Clinical Breast Cancer (2021) Vol. 22, Iss. 2, pp. e191-e198
Closed Access | Times Cited: 15

Showing 15 citing articles:

Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies
Mehrdad Hashemi, Mohammad Arad Zandieh, Yasmin Talebi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114392-114392
Open Access | Times Cited: 60

High CXCL8 expression predicting poor prognosis in triple-negative breast cancer
Sumin Tang, Yuqing Zhang, Liying Song, et al.
Anti-Cancer Drugs (2025) Vol. 36, Iss. 3, pp. 246-252
Closed Access

B Cell Activating Factor Induces Drug Resistance in Hairy Cell Leukemia Variant
Claire E. Fritz, Daniel Feinberg, Anand Radhakrishnan, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 890-890
Open Access

Exploring the Characteristics of Monkeypox-Related Genes in Pan-Cancer
Yong Liao, Zhiping Liu, Weile Ye, et al.
Cells (2022) Vol. 11, Iss. 23, pp. 3909-3909
Open Access | Times Cited: 3

Bioinformatics approach combined with experimental verification reveals OAS3 gene implicated in paclitaxel resistance in head and neck cancer
Hasan Onur Çağlar, Abdulmelik Aytatli, Neslisah Barlak, et al.
Head & Neck (2024) Vol. 46, Iss. 9, pp. 2178-2196
Open Access

Cancer stem cell-mediated drug resistance: A comprehensive gene expression profile analysis in breast cancer
Pedram Torabian, Hassan Yousefi, Aysan Fallah, et al.
Pathology - Research and Practice (2023) Vol. 246, pp. 154482-154482
Closed Access | Times Cited: 1

Immunosuppressive SOX9AS1 Resists Triple‐Negative Breast Cancer Senescence Via Regulating Wnt Signalling Pathway
Xuan Ye, Yi Cen, Quan Li, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 22
Open Access

Additional expression of T-cell engager in clinically tested oncolytic adeno-immunotherapy redirects tumor-infiltrated, irrelevant T cells against cancer cells to enhance antitumor immunity
Daisuke Morita, Amanda Rosewell Shaw, Greyson Biegert, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 12, pp. e009741-e009741
Open Access

Systemic Inflammatory Response as a Prognostic Factor in Breast Cancer. Part I. Tumor-Promoting Inflammation. Serum Inflammatory Markers
Н. С. Сергеева, Т. А. Кармакова, Marianna A. Polyak, et al.
Annals of the Russian academy of medical sciences (2022) Vol. 77, Iss. 5, pp. 345-353
Open Access | Times Cited: 1

MYC enhancer invasion promotes prognostic cancer type-specific gene programs through an epigenetic switch
Simon Toftholm Jakobsen, Rikke AM Jensen, Tina Ravnsborg, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access

CircRNA_0044556 regulates paclitaxel resistance in triple-negative breast cancer by targeting miR-665
jingjing chen, Peng Shi, zhiqiang cui, et al.
Research Square (Research Square) (2023)
Open Access

Exploiting Epigenetic Targets to Overcome Taxane Resistance in Prostate Cancer
Buse Cevatemre, Ipek Bulut, Beyza Dedeoğlu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access

Page 1

Scroll to top